As Operations Director at Exeliom Biosciences, Mathilde Delaunay spearheads the development of next-generation immunotherapies for cancer and immune-mediated diseases. A graduate of HEC Paris in biotech entrepreneurship, she has guided the companys evolution from a preclinical spin-off to a clinical-stage organization, coordinating a global network of partners and experts.
She was a key member of the team that successfully brought a pioneering drug from the laboratory to patient trials, a significant milestone she had been working towards since joining the company in 2018.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.